Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/13/2003US20030212117 Efficient process for the preparation of a factor Xa inhibitor
11/13/2003US20030212115 Remedies for inflammatory bowel diseases
11/13/2003US20030212114 Stable emulsion compositions
11/13/2003US20030212112 Method for administering a phosphodiesterase 4 inhibitor
11/13/2003US20030212110 Calcilytic compounds
11/13/2003US20030212107 R-reliprodil for treating glaucoma
11/13/2003US20030212106 Opioid formulations
11/13/2003US20030212105 Novel anti-fertility agent
11/13/2003US20030212104 Treatment of diabetes and diabetic complications with NHE-1 inhibitors
11/13/2003US20030212103 Anticancer agents; antiproliferative agents
11/13/2003US20030212102 Novel solid dispersion compositions
11/13/2003US20030212100 Antidiabetic agnets; insulin resistance
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212096 Analgesics, antiinflammatory agents, autoimmune disease, viricides, bactericides, antitumor agents, organ grafting, central nervous system disorders
11/13/2003US20030212094 Novel cyclic amide derivatives
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030212090 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
11/13/2003US20030212088 Methods and compositions for treating, preventing or delaying onset of a neoplasm
11/13/2003US20030212087 Plant extracts; antitumor, anticancer agents; topoisomerase inhibitor
11/13/2003US20030212085 Treatment of fibromyalgia and chronic fatigue syndrome
11/13/2003US20030212084 Naphthrydine compounds and their azaisosteric analogues as antibacterials
11/13/2003US20030212082 Controlling neovascularization; angiogenesis inhibitors; therapy for strokes, cardiovascular disorders; antitumor agents; antidiabetic agents; antiarthritic agents; psoriasis
11/13/2003US20030212081 Bicyclic heteroaromatic compounds useful as LH agonists
11/13/2003US20030212080 Adenosine A2a receptor antagonists
11/13/2003US20030212079 Antiischemic agents; central nervous system disorders
11/13/2003US20030212078 Topical administration of pharmacological compositions for non-systemic treatment of pruritus
11/13/2003US20030212077 Methods and compositions for treating tinea versicolor using combinations of retinoids and certain antifungals
11/13/2003US20030212075 Inhalation aerosol comprising tiotropium salt and propellant gas; respiratory system disorders
11/13/2003US20030212074 Phosphate transport inhibitors
11/13/2003US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
11/13/2003US20030212072 Salts of zopolrestat
11/13/2003US20030212071 Controlling blood coagulation
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003US20030212069 Antithrombotic amides
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030212065 Using a imidazolo(4,5,1-ij)quinoline compound
11/13/2003US20030212064 Triazolotriazinones and the use thereof
11/13/2003US20030212062 Morpholinone and morpholine derivatives and uses thereof
11/13/2003US20030212060 Combination therapy for treatment of refractory depression
11/13/2003US20030212059 Adenosine A2a receptor antagonists
11/13/2003US20030212058 Side effect reduction; osteoporosis therapy
11/13/2003US20030212057 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
11/13/2003US20030212055 Cinnoline compounds
11/13/2003US20030212053 Nanoparticulate eplerenone compositions
11/13/2003US20030212052 Induction apoptosis
11/13/2003US20030212050 Administering cyclooxygenase inhibitor and acetylsalicylic acid
11/13/2003US20030212049 Antiarthritic agents; osteoporosis; sepsis; antiulcer agents; Crohn's disease
11/13/2003US20030212048 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor
11/13/2003US20030212047 Gastrointestinal side effect reduction; administering bisphosphonate compound
11/13/2003US20030212044 Treatment of HIV
11/13/2003US20030212043 Menopause therapy; contraceptives
11/13/2003US20030212042 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
11/13/2003US20030212041 Facilitation of wound healing with CM101/GBS toxin
11/13/2003US20030212039 Oral administering mixture of folic acid and vitamins
11/13/2003US20030212038 Anticancer agents; side effect reduction; synergistic mixture of antifolic acid and reducing methylmalonic acid concentration
11/13/2003US20030212037 Use of bvdu for inhibiting the growth of hyperproliferative cells
11/13/2003US20030212036 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory heptitis
11/13/2003US20030212035 Reducing cellular stresses; adjust concentration of chaperone protein
11/13/2003US20030212034 Method of treatment of obesity and paralyzed muscle and ergogenic aids
11/13/2003US20030212033 Weight reduction and inhibition of hypertriglyceridemia medicine containing ATP as effective ingredient
11/13/2003US20030212032 Oligonucleotide N3'→P5' thiophosphoramidates: their synthesis and use
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212020 Antisense modulation of macrophage migration inhibitory factor expression
11/13/2003US20030212016 Methods and compositions for the treatment and diagnosis of body weight disorders
11/13/2003US20030212015 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
11/13/2003US20030212014 Methods fo treating conditions associated with insulin resistance with aicar, (5-amino-4-imidazole carboxamide riboside) and related compounds
11/13/2003US20030212013 Administering kinase activator by injection
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003US20030212011 Macrolides with antibacterial activity
11/13/2003US20030212009 Isoflavone derivatives
11/13/2003US20030212008 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
11/13/2003US20030212007 Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent
11/13/2003US20030212006 Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
11/13/2003US20030212004 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
11/13/2003US20030212003 Cathepsin Y for the development of a medicament for the treatment of pain
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211982 Beta turn peptidomimetic cyclic compounds
11/13/2003US20030211978 Method and composition for treatment of inflammatory bowel disease
11/13/2003US20030211967 Method for selectively inhibiting ghrelin action
11/13/2003US20030211966 Novel pharmacotherapeutic process and composition for central nervous system disorders
11/13/2003US20030211613 Methods of altering calcium transport
11/13/2003US20030211608 Antisense modulation of glycogen synthase kinase 3 beta expression
11/13/2003US20030211607 Antisense modulation of survivin expression
11/13/2003US20030211592 Methods of terminal sterilization of biological products
11/13/2003US20030211583 Egs molecules that specifically downregulae bcl-xl experession
11/13/2003US20030211547 Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption
11/13/2003US20030211545 Using enzyme inhibitors to treat neuropsychological disorders such as schizophrenia and bipolar disorder; neuroleptic agents
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211508 Antiproliferative agents; for prevention of infections; for veterinary medicine, agriculture
11/13/2003US20030211469 Using geldanamycin or radicicol to prevent viral replication and infection; viricides
11/13/2003US20030211455 Methods and compositions for identifying ligands for nuclear receptors
11/13/2003US20030211440 Methods and systems for concurrent tooth repositioning and substance delivery
11/13/2003US20030211180 Viricides, anticancer agents; side effect reduction
11/13/2003US20030211175 Binding to thaumalin protein; plant extracts; reduce glucose concentration
11/13/2003US20030211173 Lubrication composition
11/13/2003US20030211172 Composition and method for substantially reducing the deleterious effects of alcohol on the body
1 ... 5277 5278 5279 5280 5281 5282 5283 5284 5285 5286 5287 5288 5289 5290 5291 5292 5293 5294 5295 5296 5297 ... 7860